First Time Loading...
I

IX Biopharma Ltd
SGX:42C

Watchlist Manager
IX Biopharma Ltd
SGX:42C
Watchlist
Price: 0.043 SGD -10.42% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

42C Price Targets Summary
IX Biopharma Ltd

Wall Street analysts forecast 42C stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 42C is 0.25 SGD .

42C Lowest Forecast
Wall Street Target
Not Available
42C Average Forecast
Wall Street Target
0.25 SGD
481% Upside
42C Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
0.25 SGD
481% Upside
Highest
Price Target
Not Available
IX Biopharma Ltd Competitors:
Price Targets
008930
Hanmi Science Co Ltd
6% Downside
000020
Dongwha Pharm Co Ltd
63% Upside
BMY
Bristol-Myers Squibb Co
22% Upside
T
300119
Tianjin Ringpu Bio-Technology Co Ltd
21% Upside
008930
Hanmi Science Co Ltd
6% Downside
000020
Dongwha Pharm Co Ltd
63% Upside
BMY
Bristol-Myers Squibb Co
22% Upside
T
300119
Tianjin Ringpu Bio-Technology Co Ltd
21% Upside
B
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
64% Upside
2186
Luye Pharma Group Ltd
4% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
10% Upside
VLS
Vita Life Sciences Ltd
62% Downside

Revenue
Forecast

Revenue Estimate
IX Biopharma Ltd

For the last 8 years the compound annual growth rate for IX Biopharma Ltd's revenue is -3%. The projected CAGR for the next 1 year is 96%.

-3%
Past Growth
96%
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IX Biopharma Ltd

Operating Income forecast
is not available for
IX Biopharma Ltd

Net Income
Forecast

Net Income Estimate
IX Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
42C intrinsic value, competitors valuation, and company profile.
DCF Valuation
42C stock valuation using Discount Cash Flow valuation method.
Relative Valuation
42C stock valuation using valuation multiples.
Wall Street Estimates
42C price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
42C stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 42C's stock price target?
Price Target
0.25 SGD

According to Wall Street analysts, the average 1-year price target for 42C is 0.25 SGD .

What is IX Biopharma Ltd's Revenue forecast?
Projected CAGR
96%

For the last 8 years the compound annual growth rate for IX Biopharma Ltd's revenue is -3%. The projected CAGR for the next 1 year is 96%.

ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.